Can COVID-19 testing be made more sustainable during prolonged uncertainty?

Can COVID-19 testing be made more sustainable during prolonged uncertainty?

In September 2021, Delta persists as the most prevalent variant worldwide due to its high infectivity, causing surges in COVID-19 cases to the point where some areas are reopening mass testing centres. As long as COVID-19 continues to defy expectations and predictions, testing will play a key role in managing the virus - whether it’s for re-introducing activities that provide a sense of normalcy or for the surveillance of emerging variants. With some local governments incorporating mandatory testing requirements into their re-opening strategies, there is growing concern about the availability and supply-chain resilience in order to access testing reagents and supplies to support another spike in demand.

Read more

The BiosearchTech Blog

Most popular

RT-qPCR Molecular Diagnostics Assist Workers at the Forefront of Ebola Outbreak.

Posted on Thu, Sep 25, 2014 @ 11:30 AM

The largest recorded Ebola Virus Disease outbreak in history continues to devastate the West African region. This ...
Read more

Topics: Molecular Diagnostics, Real-time PCR, Biodefense

Biosearch Technologies Responds To China Influenza H7N9 Outbreak By Providing H7N9 Detection Panel

Posted on Mon, Apr 15, 2013 @ 06:00 AM

Biosearch Technologies, Inc. (Biosearch) announced today that the company has implemented a rapid response to the ...
Read more

Topics: Announcement, Product Information, Biodefense

Single molecule viral RNA analysis using Stellaris™ FISH technology

Posted on Wed, May 30, 2012 @ 01:00 PM

  Image courtesy of: http://www.cdc.gov/h1n1flu/images.htm A cooperative effort between researchers at Mount Sinai ...
Read more

Topics: Biodefense, RNA FISH

Biosearch Technologies Licenses Access to the New CDC "PDM" H1N1 Signatures

Posted on Thu, Nov 18, 2010 @ 08:08 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly ...
Read more

Topics: Announcement, Biodefense

Biosearch Technologies Awarded Second Phase II Army SBIR Grant

Posted on Wed, Oct 13, 2010 @ 08:39 AM

Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly ...
Read more

Topics: Announcement, Biodefense

New Product Line! ValuPanel™ Reagents

Posted on Tue, Apr 06, 2010 @ 08:52 AM

We are pleased to introduce ValuPanel Reagents, a new product line of mission-critical probe and primer sets that ...
Read more

Topics: Announcement, Real-time PCR, Product Information, Biodefense

On the Set of "Making of the Swine Flu Test Kit - Inside Biosearch Technologies"

Posted on Thu, Nov 19, 2009 @ 08:29 AM

Biosearch Technologies recently launched a video, Making of the Swine Flu Test Kit - Inside Biosearch Technologies, ...
Read more

Topics: Molecular Diagnostics, Real-time PCR, Biodefense

BIOSEARCH TECHNOLOGIES TAKES LICENSE TO CDC H1N1 SIGNATURES AND INFLUENZA A SUB-TYPING PATENT

Posted on Wed, Nov 04, 2009 @ 07:47 AM

Biosearch Technologies announced today that the company has licensed from the CDC the novel H1N1 Influenza signatures ...
Read more

Topics: Announcement, Molecular Diagnostics, Real-time PCR, Biodefense

FDA Awards Biosearch Technologies $3.4 MM Contract

Posted on Mon, Oct 05, 2009 @ 07:48 AM

The FDA has awarded Biosearch Technologies a five year contract for the development of multiplexed, fluorescent ...
Read more

Topics: Molecular Diagnostics, Custom Oligos, Food Safety, Biodefense

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!